Corvus Pharmaceuticals
CRVS
CRVS
54 hedge funds and large institutions have $180M invested in Corvus Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.99% less ownership
Funds ownership: 83.78% → 82.79% (-0.99%)
35% less capital invested
Capital invested by funds: $280M → $180M (-$99.3M)
Holders
54
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$4.36M | |
| 2 | +$2.99M | |
| 3 | +$426K | |
| 4 |
Renaissance Technologies
New York
|
+$413K |
| 5 |
Millennium Management
New York
|
+$393K |
Top Sellers
| 1 | -$4.41M | |
| 2 | -$3.32M | |
| 3 | -$3.11M | |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$1.19M |
| 5 |
JPMorgan Chase & Co
New York
|
-$733K |